Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study
<h4>Objective</h4> We evaluated the clinical characteristics of metabolic dysfunction-associated fatty liver disease (MAFLD) to evaluate the usefulness of the MAFLD diagnostic criteria in a resident health survey. <h4>Methods</h4> In 1056 participants of a health survey, we c...
Main Authors: | Tetsuyuki Tateda, Chikara Iino, Takafumi Sasada, Satoshi Sato, Go Igarashi, Shogo Kawaguchi, Kenichiro Mikami, Tetsu Endo, Kaori Sawada, Tatsuya Mikami, Shinsaku Fukuda, Shigeyuki Nakaji, Hirotake Sakuraba |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683607/?tool=EBI |
Similar Items
-
Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study.
by: Tetsuyuki Tateda, et al.
Published: (2022-01-01) -
Effect of Liver Fibrosis on Oral and Gut Microbiota in the Japanese General Population Determined by Evaluating the FibroScan–Aspartate Aminotransferase Score
by: Satoshi Sato, et al.
Published: (2023-08-01) -
Reduced Equol Production and Gut Microbiota Features in Men With Lean Nonalcoholic Fatty Liver Disease
by: Chikara Iino, et al.
Published: (2022-08-01) -
A Cohort Study of the Influence of the 12-Component Modified Japanese Diet Index on Oral and Gut Microbiota in the Japanese General Population
by: Satoshi Sato, et al.
Published: (2024-02-01) -
Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance
by: Takuma Hasegawa, et al.
Published: (2020-05-01)